ReviewCells, tissues, organs2026
Role of the Proteasome System in Shaping Cellular Immunological Characteristics and Its Impact in Modulating the Pathogenesis of Immune-Related Diseases.
Review in Cells, tissues, organs, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe 26S proteasome degradation system is a central regulator of protein homeostasis and immune function, integrating antigen processing, inflammatory signaling, and cell fate decisions. Dysregulation of this system has profound consequences for immune tolerance, immune evasion, and immune-mediated pathology. SUMMARY: In this review, we examine the roles of the constitutive 26S proteasome and the inducible immunoproteasome in shaping cellular immunological characteristics, with a particular focus on mesenchymal stem cells and cancer cells, two cell types that exhibit context-dependent immune privilege. We discuss how proteasome dynamics regulate antigen presentation, cytokine production, and the expression of immune checkpoint and immunomodulatory molecules under physiological and stress conditions such as hypoxia and metabolic imbalance. We also summarize evidence linking altered proteasome function to the pathogenesis of autoimmune, immunodeficiency, and autoinflammatory diseases. KEY MESSAGES: The proteasome system is a pivotal molecular hub controlling immune visibility and immune escape. Understanding how distinct proteasome isoforms operate in different microenvironments will be essential for developing targeted immunomodulatory and proteasome-based therapeutic strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.